FDA Warns of Overdoses of Anti-Diarrhea Drug

Share this content:
FDA Warns of Overdoses of Anti-Diarrhea Drug
FDA Warns of Overdoses of Anti-Diarrhea Drug

WEDNESDAY, June 8, 2016 (HealthDay News) -- Overdoses from common anti-diarrhea drugs are being investigated by the U.S. Food and Drug Administration, which warned the drugs can cause potentially fatal heart problems when taken in higher-than-recommended amounts.

Loperamide is the main ingredient in prescription Imodium and similar non-prescription drugs meant to control diarrhea. Most of the reported serious heart problems have occurred in individuals who were intentionally misusing/abusing high doses of loperamide in attempts to self-treat opioid withdrawal symptoms or to achieve a feeling of euphoria, the FDA reported.

The FDA notes that the risk of serious heart problems, including abnormal heart rhythms, may be further increased when high doses of loperamide are taken with several kinds of medicines that interact with loperamide. These medications include cimetidine, erythromycin, ketoconazole, and ranitidine.

"Health care professionals should be aware that use of higher than recommended doses of loperamide can result in serious cardiac adverse events," the FDA said in a June 7 safety announcement. "Consider loperamide as a possible cause of unexplained cardiac events, including QT interval prolongation, Torsades de Pointes or other ventricular arrhythmias, syncope, and cardiac arrest."

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

High Success Rates for Mitral Valve Repair With Robotic Surgery

High Success Rates for Mitral Valve Repair With ...

Minimally invasive surgery linked to fewer discharges to facility, one day less in hospital vs conservative sx

Tattoo-Linked Complications ID'd in Immunosuppressed Female

Tattoo-Linked Complications ID'd in Immunosuppressed Female

Inflammatory myopathy identified in woman with cystic fibrosis on long-term immunosuppressants

Rates of Cardiac Stress Testing Down but Still Higher in CKD

Rates of Cardiac Stress Testing Down but Still ...

Decline in rates of cardiac stress testing in Medicare beneficiaries aged ≥66 years from 2008 to 2012

is free, fast, and customized just for you!




Already a member?

Sign In Now »